Third European Medicines Agency (EMA) and MedTech Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 2 July 2024

Third European Medicines Agency (EMA) and MedTech Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 2 July 2024

Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation: 06/11/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation: 06/11/2023, Revision: 2, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness